AiCure, LLC is a New York-based company that offers innovative solutions for enhancing drug development in clinical trials. Their Patient Connect platform improves medication adherence rates and patient engagement, while their AiCure Platform enables the analysis and prediction of treatment response using digital biomarkers. With AiCure Site Services, clinical tech burden is reduced, allowing site personnel to focus more on patient care.
AiCure also promotes collaboration and research through their OpenDBM platform, which provides access to their digital biomarker algorithms for measuring patient behavior. Their secure, patient-facing application supports data collection for traditional, decentralized, or hybrid trials, providing a comprehensive view of therapy's impact on patients. Through their cutting-edge solutions, AiCure is revolutionizing the field of clinical research and driving innovation in drug development.
Generated from the website